reglab/statecodes huggingface dataset:
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 701 - POLICIES AND PROCEDURES › Section 701.19 - Texas Location for Grant Awards

Current through Reg. 49, No. 28; July 12, 2024
(a)
				Except as addressed by the Request for Applications or this rule, only
				Texas-based entities are eligible to receive Grant Awards.
(b) Grant Applicants responding to a Request
				for Applications may be located outside the state of Texas when the Grant
				application is submitted and reviewed. However, the Institute requires the
				Grant Applicant to demonstrate that it will relocate to Texas as a condition of
				the Grant Award.
(c) A Grant
				Applicant for a Product Development Grant Award may demonstrate compliance with
				subsection (b) by fulfilling a majority of the following requirements:
(1) The U.S. headquarters is physically
				located in Texas;
(2) The Chief
				Executive Officer resides in Texas;
(3) A majority of the company's personnel,
				including at least two other C-level employees (or equivalent) reside in Texas;
(4) Manufacturing activities take
				place in Texas;
(5) At least 90%
				of Grant Award funds are paid to individuals and entities in Texas, including
				salaries and personnel costs for employees and contractors;
(6) At least one clinical trial site in
				Texas; and
(7) Collaboration with
				a medical research organization in Texas, including a public or private
				institution of higher education.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 701 - POLICIES AND PROCEDURES › Section 701.21 - Preference for Texas Suppliers for Purchases Made by Grant Recipients

Current through Reg. 49, No. 28; July 12, 2024
It is the policy of the Institute to encourage the purchase
				  of goods and services required for the Grant Award from suppliers in the State
				  to the extent reasonably possible. A Grant Recipient shall undertake good faith
				  efforts to purchase from suppliers in the State at least fifty percent (50%) of
				  the goods and services purchased with Grant Award funds.
(1) A Grant Recipient must use good faith
				efforts to purchase goods and services from suppliers in the State when
				available at a price and time comparable to products and materials purchased
				outside of the State.
(2) A Grant
				Recipient that expends more than forty percent (40%) of the Grant Award funds
				budgeted for a Project Year on goods and services purchased outside of the
				State must notify the Institute in writing and provide an explanation of the
				good faith efforts undertaken to purchase the goods or services from suppliers
				in the State, including a statement that products and materials were not
				available in the State at a comparable price and time. Such notification and
				explanation may be accomplished by completing the Historically Underutilized
				Business and Texas Supplier form submitted as part of the annual Grant Progress
				Report.
(3) The Institute may deny
				reimbursement or require repayment of Grant Award funds already expended if the
				Grant Recipient fails to provide a statement as required by paragraph (2) of
				this section with a reasonable explanation of the good faith efforts undertaken
				to purchase the goods or services from suppliers in the State of
				Texas.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 701 - POLICIES AND PROCEDURES › Section 701.23 - Historically Underutilized Businesses Policy for Grant Recipients

Current through Reg. 49, No. 28; July 12, 2024
It is the policy of the Institute to encourage the use of
				  historically underutilized businesses (HUBs) by Grant Recipients to promote
				  full and equal business opportunities for all businesses.
(1) A Grant Recipient is expected to
				undertake good faith efforts to utilize HUBs in subcontracts for construction,
				commodities purchases, and other services, including professional and
				consulting services, paid for with Grant Award funds.
(2) A Grant Recipient must report to the
				Institute at least annually regarding efforts undertaken by the Grant Recipient
				to utilize HUBs in the performance of the Grant Contract by completing the
				Historically Underutilized Business and Texas Supplier form submitted as part
				of the annual Grant Progress Report.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 701 - POLICIES AND PROCEDURES › Section 701.25 - Electronic Signature Policy

Current through Reg. 49, No. 28; July 12, 2024
A Grant Recipient's use of the Institute's electronic Grant Management
											  System or a Grant Applicant's use of the Institute's electronic Application Receipt System to create,
											  exchange, execute, submit, and verify legally binding Grant Contract documents and Grant Award reports or a
											  Grant Application shall be pursuant to an agreement between the Institute and the Grant Recipient or Grant
											  Applicant regarding the use of binding electronic signatures. Such agreement shall include at least the
											  following minimum standards:
(1) The Grant Recipient or Grant
										Applicant agrees that by entering the Authorized Signing Official's password in the electronic Grant
										Management System or Application Receipt System at certain specified points, the Grant Recipient or Grant
										Applicant electronically signs the Grant Contract document or related form or Grant Application. The Grant
										Recipient or Grant Applicant further agrees that the electronic signature is the legal equivalent of the
										Authorized Signing Official's manual signature.
(2) The Institute
										may rely upon the electronic signature rendered by entering the Authorized Signing Official's password as
										evidence that the Grant Recipient or Grant Applicant consents to be legally bound by the terms and conditions
										of the Grant Contract or related form or Grant Application as if the document was manually signed.
(3) The Grant Recipient or Grant Applicant shall provide prompt written
										notification to the Institute of any changes regarding the status or authority of the individual(s)
										designated by the Grant Recipient or Grant Applicant to be the Grant Recipient's or Grant Applicant's
										Authorized Signing Official. The notice must be provided to an individual designated by the
										Institute.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 701 - POLICIES AND PROCEDURES › Section 701.27 - Publicly Available Institute Reports and Record

Current through Reg. 49, No. 28; July 12, 2024
To promote transparency in its activities, the Institute
				  maintains the information described in this section and makes such information
				  publicly available through the Institute's Internet website or upon
				  request.
(1) The Texas Cancer
				Plan;
(2) The Institute's Annual
				Public Report;
(3) The Conflict of
				Interest information described in this paragraph for the previous 12 months:
(A) A list of disclosed Conflicts of Interest
				requiring recusal.
(B) Any
				unreported Conflicts of Interest confirmed by an Institute investigation and
				actions taken by the Institute regarding same.
(C) Any Conflict of Interest waivers
				granted.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 701 - POLICIES AND PROCEDURES › Section 701.29 - Third-Party Information Held by the Institute

Current through Reg. 49, No. 28; July 12, 2024
(a) In order to protect the actual or
				potential value of information submitted to the Institute by a Grant Applicant
				or a Grant Recipient, the Institute shall undertake reasonable efforts to
				protect Third-Party Information as described herein from unauthorized public
				disclosure, consistent with the requirements of Chapter 552, Texas Government
				Code.
(b) With the exception of
				information set forth in subsection (g) of this section, the Institute shall
				consider the following material confidential:
(1) Information that relates to a Grant
				Applicant's or Grant Recipient's product, device, or process that has the
				potential for being sold, traded, or licensed for a fee, including the
				application or use of such product, device, or process;
(2) All technological or scientific
				information developed in whole or in part by the Grant Applicant or Grant
				Recipient that has the potential for being sold, traded, or licensed for a
				fee;
(3) All information that
				relates to the plans, specifications, blueprints, and designs, including
				related proprietary information, of a scientific research and development
				facility;
(4) Written comments made
				by one or more Scientific Research and Prevention Programs Committee Members
				that reveals, directly or indirectly, information relating to the Grant
				Applicant's or Grant Recipient's product, device, or process that has the
				potential for being sold, traded, or licensed for a fee, including the
				application or use of such product, device, or process; and
(5) Information included in the business
				operations and management due diligence and intellectual property reviews
				conducted for the Grant Review Process that reveals, directly or indirectly,
				information relating to the Grant Applicant's or Grant Recipient's product,
				device, or process that has the potential for being sold, traded, or licensed
				for a fee.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 701 - POLICIES AND PROCEDURES › Section 701.31 - Charges for Copies of Public Records

Current through Reg. 49, No. 28; July 12, 2024
(a)
				The charge to any person requesting copies of any public record of the
				Institute will be:
(1) Standard paper
				copy--$.10 per page.
(2)
				Nonstandard-size copy:
(A) Diskette:
				$1.00;
(B) Magnetic tape: actual
				cost;
(C) Data cartridge: actual
				cost;
(D) Tape cartridge: actual
				cost;
(E) Rewritable CD
				(CD-RW)--$1.00;
(F) Non-rewritable
				CD (CD-R)--$1.00;
(G) Digital video
				disc (DVD)--$3.00;
(H) JAZ
				drive--actual cost;
(I) Other
				electronic media--actual cost;
(J)
				VHS video cassette--$2.50;
(K)
				Audio cassette--$1.00;
(L) Oversize
				paper copy (e.g.: 11 inches by 17 inches, greenbar, bluebar, not including maps
				and photographs using specialty paper)--$.50 per page;
(M) Specialty paper (e.g.: Mylar, blueprint,
				blueline, map, photographic)--actual cost.
(3) Labor charge:
(A) For programming--$28.50 per
				hour;
(B) For locating, compiling,
				and reproducing--$15 per hour.
(4) Overhead charge--20% of labor
				charge.
(5) Microfiche or microfilm
				charge:
(A) Paper copy--$.10 per
				page;
(B) Fiche or film
				copy--Actual cost.
(6)
				Remote document retrieval charge--Actual cost.
(7) Computer resource charge:
(A) Mainframe--$10 per CPU minute;
(B) Midsize--$1.50 per CPU minute;
(C) Client/Server system--$2.20 per clock
				hour;
(D) PC or LAN--$1.00 per
				clock hour.
(8)
				Miscellaneous supplies--Actual cost.
(9) Postage and shipping charge--Actual
				cost.
(10) Photographs--Actual
				cost.
(11) Maps--Actual
				cost.
(12) Other costs--Actual
				cost.
(13) Outsourced/Contracted
				Services--Actual cost for the copy.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 701 - POLICIES AND PROCEDURES › Section 701.33 - Negotiation and Mediation of Certain Breach of Contract Claims

Current through Reg. 49, No. 28; July 12, 2024
(a) In accordance
				with Texas Government Code §
									2260.052(c),
				the Institute adopts herein by reference the model rules provided by the Office
				of the Attorney General relating to procedures for the negotiation and
				mediation of certain contract claims asserted by contractors against the
				Institute.
(b) The procedures, as
				adopted, are exclusive and required prerequisites to suit against the Institute
				under the Texas Civil Practice and Remedies Code, Chapter 107, and the Texas
				Government Code, Chapter 2260.
(c)
				Nothing herein waives the Institute's sovereign immunity to suit or
				liability.
(d) Unless specifically
				provided for by the Grant Contract, this rule does not apply to Grant
				Contracts. The Grant Contract shall specify the process and procedures for
				terminating a Grant Award, as well as any associated remedy.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 701 - POLICIES AND PROCEDURES › Section 701.35 - Petition for Adoption of Rules

Current through Reg. 49, No. 28; July 12, 2024
(a) An
				interested party may petition the Institute to adopt a rule by submitting a
				proposed rule in writing either by electronic or regular mail to the Chief
				Executive Officer and the General Counsel of the Institute. Each proposed rule
				must be submitted to the Institute in a separate petition for adoption.
(b) The petition must include the
				following information:
(1) the full name,
				mailing address, email address, and phone number of the petitioner;
(2) the complete text of the new proposed
				rule, if the proposed rule alters text of a current Institute rule then changes
				shall be shown in the following manner, deletion of current text shall be
				marked by striking through the text, addition of new text shall be marked by
				underlining the text;
(3) an
				explanation of how the proposed rule benefits the public, including supporting
				information or data demonstrating the need for the proposed rule;
(4) a statement of the legal authority for
				the proposed rule; and
(5) any
				other information required by the Institute.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 701 - POLICIES AND PROCEDURES › Section 701.37 - Grant Recipient Travel Policy

Current through Reg. 49, No. 28; July 12, 2024
(a)
				Travel costs for Grant Recipients are allowable based on the State of Texas
				travel policy, administered by the Texas Comptroller of Public Accounts,
				provided that costs are deemed by the Institute to be reasonable and necessary.
				The Institute will not reimburse a Grant Recipient for travel expenses in an
				amount that exceeds the standards in the State of Texas travel
				policy.
(b) Grant Recipients must
				provide adequate supporting documentation when requesting reimbursement for
				travel expenses on a Financial Status Report pursuant to §703.24.
(1) A separate travel expense report should
				be submitted for each trip taken.
(2) Meal costs may be charged on an actual
				cost basis or on a per diem, provided that one method is used uniformly on an
				entire trip.
(3) Lodging expenses
				must be supported with either a receipt or, if a receipt is unavailable, the
				canceled check or credit card slip used to pay the lodging expense, the credit
				card billing on which the lodging charges appear, or a copy of the check, slip
				or billing.
(4) Mileage must be
				supported with a detailed record of actual point-to-point mileage with odometer
				readings or copies of mapping website mileage. Mileage should not be rounded to
				the nearest decimal point.
(5)
				Transportation expenses must be supported with a receipt or itinerary. If
				neither is available then a Grant recipient should provide the canceled check
				or credit card slip used to pay for the transportation, the credit card billing
				on which the transportation charges appear, or a copy of the receipt, check,
				slip or billing.
(6) Rental of
				motor vehicles must be supported by a receipt and/or rental contract.
(7) Incidental expenses must be supported by
				an itemization of the expenses incurred.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 702 - INSTITUTE STANDARDS ON ETHICS AND CONFLICTS, INCLUDING THE ACCEPTANCE OF GIFTS AND DONATIONS TO THE INSTITUTE › Section 702.1 - Authority

Current through Reg. 49, No. 28; July 12, 2024
This chapter is adopted pursuant to and in satisfaction of
				  the provisions of Texas Government Code Annotated, Chapters 572 and 2255, Texas
				  Health and Safety Code, Chapter 102, and other relevant
				  statutes.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 702 - INSTITUTE STANDARDS ON ETHICS AND CONFLICTS, INCLUDING THE ACCEPTANCE OF GIFTS AND DONATIONS TO THE INSTITUTE › Section 702.3 - Definitions

Current through Reg. 49, No. 28; July 12, 2024
The words and terms used in this chapter shall have the
				  meanings provided in Chapter 701, §
									701.3 of
				  this title (relating to Definitions), unless the context clearly indicates
				  otherwise.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 702 - INSTITUTE STANDARDS ON ETHICS AND CONFLICTS, INCLUDING THE ACCEPTANCE OF GIFTS AND DONATIONS TO THE INSTITUTE › Section 702.5 - Intent

Current through Reg. 49, No. 28; July 12, 2024
It is the intent of the Institute that the Institute's Grant
				  Review process provide Grant Applicants a fair and unbiased merit-based
				  assessment free from conflicts of interest, impropriety and self-dealing. To
				  implement this policy, this chapter provides standards of conduct and conflict
				  of interest disclosure requirements to be observed by those individuals that
				  are a part of the Grant Review Process and the execution of Grant Contracts.
				  Individuals subject to this chapter include Oversight Committee Members,
				  Program Integration Committee Members, Scientific Research and Prevention
				  Programs Committee Members, and Institute Employees. Independent contractors,
				  such as outside legal counsel, grant management system contractors, and subject
				  matter experts, shall be subject to applicable provisions of this chapter to
				  the extent that the individuals are performing duties associated with Grant
				  Applications under consideration for Grant Awards.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 702 - INSTITUTE STANDARDS ON ETHICS AND CONFLICTS, INCLUDING THE ACCEPTANCE OF GIFTS AND DONATIONS TO THE INSTITUTE › Section 702.7 - Acceptance of Gifts and Donations by the Institute

Current through Reg. 49, No. 28; July 12, 2024
(a) As authorized by Texas Health and Safety
				Code §
									102.054, the
				Institute may solicit and accept gifts from any source to support the
				operations of the Institute and to further its purposes; except that the
				Institute may not supplement the salary of any Institute Employee with a gift
				or grant received by the Institute.
(b) An Oversight Committee Member or an
				Institute Employee shall not authorize a donor to use the property of the
				Institute unless the property is used in accordance with a contract between the
				Institute and the donor, the contract is found by the Institute to serve a
				public purpose, the contract contains provisions to ensure the public purpose
				continues, and the Institute is reasonably compensated for the use of the
				property.
(c) Procedure for
				acceptance of gifts.
(1) Gifts to the
				Institute may be designated for one of the following categories:
(A) Unrestricted General Support;
(B) Restricted Programmatic
				Support;
(C) Endowed and Restricted
				Funds; or
(D) Other (includes gifts
				of real or personal property).
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 702 - INSTITUTE STANDARDS ON ETHICS AND CONFLICTS, INCLUDING THE ACCEPTANCE OF GIFTS AND DONATIONS TO THE INSTITUTE › Section 702.11 - Conflicts of Interest Requiring Recusal

Current through Reg. 49, No. 28; July 12, 2024
(a) For purposes of this chapter, a Conflict
				of Interest exists when an individual subject to this rule has an interest in
				the outcome of a Grant Application submitted by an entity receiving or applying
				to receive money from the Institute such that the individual is in a position
				to gain financially, professionally, or personally from either a positive or
				negative evaluation of the Grant Application. Individuals subject to this rule
				are:
(1) Oversight Committee
				Members;
(2) Institute
				employees;
(3) Scientific Research
				and Prevention Programs Committee Members;
(4) Program Integration Committee Members;
				and
(5) Independent Contractors
				that perform services associated with the Grant Review Process on behalf of the
				Institute, such as facilitating grant review activities, evaluating the
				intellectual property held by or licensed to a Grant Applicant, or performing a
				business management due diligence review.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 702 - INSTITUTE STANDARDS ON ETHICS AND CONFLICTS, INCLUDING THE ACCEPTANCE OF GIFTS AND DONATIONS TO THE INSTITUTE › Section 702.13 - Disclosure of Conflict of Interest and Recusal from Review

Current through Reg. 49, No. 28; July 12, 2024
(a) If an Oversight Committee Member or a
				Program Integration Committee Member has a Conflict of Interest as described in
				this chapter with respect to an entity or Grant Application that comes before
				the individual for review or other action, the Member shall:
(1) Provide written notice of the Conflict of
				Interest to the Chief Executive Officer and the presiding officer of the
				Oversight Committee (or the next ranking member of the Oversight Committee if
				the presiding officer has the Conflict of Interest). For purposes of this
				requirement, an Oversight Committee member or Program Integration Committee
				member who designates the Conflict of Interest on the secure website provided
				to review the recommended Grant Awards is deemed to have provided written
				notice;
(2) Disclose the Conflict
				of Interest in an open meeting of the Oversight Committee; and
(3) Recuse himself or herself from
				participation in the review, discussion, deliberation and vote on the entity or
				Grant Application, including access to information regarding the matter to be
				decided, unless a waiver has been granted pursuant to §
										702.15
				of this chapter (relating to Investigation of Unreported Conflicts of Interest
				Affecting the Grant Review Process).
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 702 - INSTITUTE STANDARDS ON ETHICS AND CONFLICTS, INCLUDING THE ACCEPTANCE OF GIFTS AND DONATIONS TO THE INSTITUTE › Section 702.15 - Investigation of Unreported Conflicts of Interest Affecting the Grant Review Process

Current through Reg. 49, No. 28; July 12, 2024
(a) An Oversight
				Committee Member, a Program Integration Committee Member, a Scientific Research
				and Prevention Programs Committee Member, or an Institute Employee who becomes
				aware of a potential Conflict of Interest described by §
									702.11
				of this chapter (relating to Conflicts of Interest Requiring Recusal) that has
				not been reported shall immediately notify the Chief Executive Officer of the
				potential Conflict of Interest. If the potential Conflict of Interest is held
				by the Chief Executive Officer, then the report shall be made directly to the
				presiding officer of the Oversight Committee. Upon notification, the Chief
				Executive Officer must notify the presiding officer of the Oversight Committee
				and the General Counsel of the unreported conflict.
(b) A Grant Applicant seeking an
				investigation regarding whether an individual subject to this chapter failed to
				report a Conflict of Interest described by §
									702.11
				of this chapter shall file a written request with the Institute's Chief
				Executive Officer. The Grant Applicant shall:
(1) Provide all facts regarding the alleged
				Conflict of Interest known to the Grant Applicant requesting the investigation;
				and
(2) Submit the request for
				investigation not later than the 30th day after the Chief Executive Officer
				presents final funding recommendations for the affected Grant Review Cycle to
				the Oversight Committee. Nothing herein prohibits the Chief Executive Officer
				from initiating an investigation if the Grant Applicant fails to submit the
				request by the deadline set herein, so long as the Grant Applicant shows good
				cause for failing to meet the deadline.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 702 - INSTITUTE STANDARDS ON ETHICS AND CONFLICTS, INCLUDING THE ACCEPTANCE OF GIFTS AND DONATIONS TO THE INSTITUTE › Section 702.17 - Exceptional Circumstances Requiring Participation

Current through Reg. 49, No. 28; July 12, 2024
In exceptional cases, as determined by a vote of the simple
				  majority of the Oversight Committee present and voting, the participation of an
				  Oversight Committee Member, Institute Employee, Program Integration Committee
				  Member, independent contractor, or Scientific Research and Prevention Programs
				  Committee Member in the Grant Review Process, the Grant Contract process, or
				  the monitoring of the Grant Award outweighs the potential bias posed by a
				  Conflict of Interest held by the individual and a waiver from recusal required
				  by §
									702.13
				  of this chapter (relating to Disclosure of Conflict of Interest and Recusal
				  from Review) may be granted by the Oversight Committee, unless otherwise
				  prohibited by state or federal law.
(1) The Chief Executive Officer or an
				Oversight Committee Member may propose granting a waiver on behalf of the
				Oversight Committee Member, the Institute Employee, the Program Integration
				Committee Member, independent contractor, or the Scientific Research and
				Prevention Programs Committee Member by submitting a written statement to the
				presiding officer of the Oversight Committee. The statement must include:
(A) information about the Conflict of
				Interest, including the name and position of the person with the conflict to be
				waived;
(B) the exceptional
				circumstances justifying a waiver of one or more of the Institute's Conflict of
				Interest provisions;
(C) that the
				integrity of the Grant Review Process, the Grant Contract process, the
				monitoring of Grant Awards, or committee action would not be impaired by the
				individual's participation; and
(D)
				any proposed limits on certain activities to be taken by the
				individual.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 702 - INSTITUTE STANDARDS ON ETHICS AND CONFLICTS, INCLUDING THE ACCEPTANCE OF GIFTS AND DONATIONS TO THE INSTITUTE › Section 702.19 - Restriction on Communication Regarding Pending Grant Application

Current through Reg. 49, No. 28; July 12, 2024
(a) Communication
				regarding the substance of a pending Grant Application between the Grant
				Applicant and an Oversight Committee Member, a Program Integration Committee
				Member, or a Scientific Research and Prevention Programs Committee Member is
				prohibited.
(b) The prohibition on
				communication begins on the first day that Grant Applications for the Grant
				Mechanism are accepted by the Institute and extends until the Grant Applicant
				receives notice regarding a final decision on the Grant Application.
(1) The prohibition on communication does not
				apply to the time period when pre-applications or letters of interest are
				accepted.
(2) In special
				circumstances, an Oversight Committee Member or a Program Integration Committee
				Member may respond to a question or request for more information from a Grant
				Applicant so long as the response is made available to all Grant
				Applicants.
(3) The prohibition
				does not apply to a Scientific Research and Prevention Programs Committee
				Member who is assigned by the Product Development Review Council chairperson to
				participate in the business operations and management due diligence review and
				intellectual property review as described in Chapter 703 of this title
				(relating to Grants for Cancer Prevention and Research). A Scientific Research
				and Prevention Programs Committee Member, on behalf of the Product Development
				Review Council, may participate in the due diligence review process and ask
				clarifying questions of a Grant Applicant to gain substantive knowledge, which
				the Product Development Review Council will use in the review of the Grant
				Application.
(A) Each Grant Application
				recommended to the due diligence stage of review will be subject to the same
				review and participation by a Scientific Research and Prevention Programs
				Committee Member as described in paragraph (3) of this subsection.
(B) The Institute will maintain documentation
				of the Scientific Research and Prevention Programs Committee Members assigned
				to participate in due diligence review.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 702 - INSTITUTE STANDARDS ON ETHICS AND CONFLICTS, INCLUDING THE ACCEPTANCE OF GIFTS AND DONATIONS TO THE INSTITUTE › Section 702.21 - Availability of Information

Current through Reg. 49, No. 28; July 12, 2024
The members of the Oversight Committee shall receive training
				  on the Texas Public Information Act and the Texas Open Meetings Act after the
				  conclusion of each regular session of the Texas Legislature. This requirement
				  is in addition to any statutorily required training and may be met by attending
				  a training session during a meeting of the Oversight Committee, or via other
				  form of in-person, video, or on-line training approved by the Attorney
				  General.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.1 - Purpose and Application

Current through Reg. 49, No. 28; July 12, 2024
(a) Grant
				Awards from the Institute shall fund:
(1)
				Research into the causes of and cures for all types of cancer in
				humans;
(2) Facilities for use in
				research into the causes and cures for cancer;
(3) Research, including translational
				research, to develop therapies, protocols, medical pharmaceuticals, or
				procedures for the cure or substantial mitigation of all types of cancer in
				humans;
(4) Cancer Prevention and
				Control Programs in this state to mitigate the incidence of all types of cancer
				in humans;
(5) Support for
				institutions of learning and advanced medical research facilities and
				collaborations in this state in all stages in the process of finding the causes
				of all types of cancer in humans and developing cures, from laboratory research
				to clinical trials and including programs to address the problem of access to
				advanced cancer treatment; and
(6)
				Implementation of the Texas Cancer Plan.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.2 - Definitions

Current through Reg. 49, No. 28; July 12, 2024
The words and terms, when used in this chapter, shall have
				  the meanings provided in Chapter 701, §
									701.3 of
				  this title (relating to Definitions), unless the context clearly indicates
				  otherwise.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.3 - Grant Applications

Current through Reg. 49, No. 28; July 12, 2024
(a) The
				Institute shall accept Grant Applications for Cancer Research and Cancer
				Prevention programs to be funded by the Cancer Prevention and Research Fund or
				the proceeds of general obligation bonds issued on behalf of the Institute in
				response to standard format Requests for Applications issued by the
				Institute.
(b) Each Request for
				Applications shall be publicly available through the Institute's Internet
				website. The Institute reserves the right to modify the format and content
				requirements for the Requests for Applications from time to time. Any
				modifications will be available through the Institute's Internet website. The
				Request for Applications shall:
(1) Include
				guidelines for the proposed projects and may be accompanied by instructions
				provided by the Institute.
(2)
				State the criteria to be used during the Grant Review Process to evaluate the
				merit of the Grant Application, including guidance regarding the range of
				possible scores.
(A) The specific criteria
				and scoring guidance shall be developed by the Chief Program Officer in
				consultation with the Review Council.
(B) When the Institute will use a preliminary
				evaluation process as described in §
											703.6 of
				this chapter (relating to Grant Review Process) for the Grant Applications
				submitted pursuant to a particular Grant Mechanism, the Request for
				Applications shall state the criteria and Grant Application components to be
				included in the preliminary evaluation.
(3) Specify limits, if any, on the number of
				Grant Applications that may be submitted by an entity for a particular Grant
				Mechanism to ensure timely and high-quality review when a large number of Grant
				Applications are anticipated.
(4)
				Specify the minimum level of effort, if any, for the Principal Investigator,
				co-Principal Investigator, and other specified key personnel of an entity
				approved for a Grant Award.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.4 - Grants Management System

Current through Reg. 49, No. 28; July 12, 2024
The Institute may engage third-party grants management
				  services. Such services may include the deployment and maintenance of an
				  electronic Grants Management System to facilitate the Institute's receipt and
				  review of Grant Applications, execution of Grant Contracts, and the ongoing
				  monitoring and management of Grant Awards, including required Grant Recipient
				  reports and submissions.
(1) The
				Institute may use the electronic Grants Management System to:
(A) Facilitate the Institute's receipt and
				review of Grant Applications;
(B)
				Maintain complete Grant Review Process records for Grant Applications
				undergoing Peer Review, including the final Overall Evaluation Score and
				Numerical Ranking Score assigned to Grant Applications during the Peer Review
				Process;
(C) Maintain supporting
				documentation regarding the implementation of the Institute's Conflict of
				Interest process for each Grant Review Cycle, including a list of any Conflicts
				of Interest requiring recusal, any unreported Conflicts of Interest confirmed
				by an investigation and the actions taken, any waivers, the identity of the
				Primary Investigator, Program Director or Company Representative and the
				funding sources for the Grant Award project;
(D) Expedite execution of Grant Contracts and
				the electronic submission of Grant Contract change requests and required Grant
				Award reports;
(E) Maintain
				complete Grant Award records, including the Grant Contract and Matching Funds
				certification, required Grant Award financial reports and Grant Progress
				Reports, and the Institute's review of those reports;
(F) Support the Institute's Grant Award
				compliance monitoring by tracking the due dates and submission status for
				required Grant Award reports; and
(G) Monitor the status of past-due required
				Grant Award financial reports and Grant Progress Reports.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.6 - Grant Review Process

Current through Reg. 49, No. 28; July 12, 2024
(a) For all Grant Applications that are not administratively withdrawn by the Institute for noncompliance or otherwise withdrawn by the Grant Applicant, the Institute shall use a two-stage Peer Review process.
(1) The Peer Review process, as described herein, is used to identify and recommend meritorious Cancer Research projects, including those projects with Cancer Research Product Development prospects, and evidence-based Cancer Prevention and Control projects for Grant Award consideration by the Program Integration Committee and the Oversight Committee.
(2) Peer Review will be conducted pursuant to the requirements set forth in Chapter 702 of this title (relating to Institute Standards on Ethics and Conflicts, Including the Acceptance of Gifts and Donations to the Institute) and Chapter  102, Texas Health and Safety Code.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.8 - Oversight Committee Consideration of the Program Integration Committee's Funding Recommendation

Current through Reg. 49, No. 28; July 12, 2024
The Oversight Committee must vote to approve each Grant Award
				  recommendation submitted by the Program Integration Committee.
(1) Prior to the Oversight Committee's
				consideration and approval of the Program Integration Committee's Grant Award
				recommendations, the Chief Compliance Officer must review the process
				documentation for each Grant Application recommended for a Grant Award by the
				Program Integration Committee and report the findings to the Chief Executive
				Officer and to the Oversight Committee. The Chief Compliance Officer's report
				shall:
(A) Publicly certify that the Grant
				Review Process complied with the Institute's administrative rules and
				procedures, including those procedures stated in the Request for
				Applications.
(B) Indicate
				variances, if any, from the Institute's administrative rules and procedures
				with a Grant Application or the Grant Review Process.
(C) Compare the list of Grant Applicants
				recommended for a Grant Award to a list of donors from any nonprofit
				organization established to provide support to the Institute.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.9 - Limitation on Review of Grant Process

Current through Reg. 49, No. 28; July 12, 2024
(a)
				The decision to recommend a Grant Application for funding is based upon the
				sufficiency, merit, and, if applicable, Product Development prospects of the
				Grant Application, as determined by the Institute's Peer Review and Program
				Review processes as described in this chapter.
(b) By submitting a Grant Application, the
				Grant Applicant understands and accepts that grounds for reconsideration of the
				Institute's final decision regarding a Grant Application are limited to an
				undisclosed Conflict of Interest as set forth in Chapter 702 of this title
				(relating to Institute Standards on Ethics and Conflicts, Including the
				Acceptance of Gifts and Donations to the Institute).
(c) The Grant Applicant shall file a request
				with the Chief Executive Officer for a review of the Grant Review Process based
				on the undisclosed Conflict of Interest pursuant to the process and timeline
				set forth in Chapter 702 of this title.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.10 - Awarding Grants by Contract

Current through Reg. 49, No. 28; July 12, 2024
(a) The Oversight
				Committee shall negotiate on behalf of the state regarding the awarding of
				grant funds and enter into a written contract with the Grant
				Recipient.
(b) The Oversight
				Committee may delegate Grant Contract negotiation duties to the Chief Executive
				Officer and the General Counsel for the Institute. The Chief Executive Officer
				may enter into a written contract with the Grant Recipient on behalf of the
				Oversight Committee.
(c) The Grant
				Contract shall include the following provisions:
(1) If any portion of the Grant Contract has
				been approved by the Oversight Committee to be used to build a capital
				improvement, the Grant Contract shall specify that:
(A) The state retains a lien or other
				interest in the capital improvement in proportion to the percentage of the
				Grant Award amount used to pay for the capital improvement; and
(B) If the capital improvement is sold, then
				the Grant Recipient agrees to repay to the state the Grant Award used to pay
				for the capital improvement, with interest, and share with the state a
				proportionate amount of any profit realized from the sale;
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.11 - Requirement to Demonstrate Available Funds for Cancer Research Grants

Current through Reg. 49, No. 28; July 12, 2024
(a) Prior to the
				disbursement of Grant Award funds, the Grant Recipient of a Cancer Research
				Grant Award shall demonstrate that the Grant Recipient has an amount of
				Encumbered Funds equal to at least one-half of the Grant Award available and
				not yet expended that are dedicated to the research that is the subject of the
				Grant Award.
(1) The Grant Recipient's
				written certification of Matching Funds, as described in this section, shall be
				included in the Grant Contract.
(2)
				A Grant Recipient of a multiyear Grant Award may certify Matching Funds on a
				year-by-year basis for the amount of Award Funds to be distributed for the
				Project Year based upon the Approved Budget.
(3) A Grant Recipient receiving multiple
				Grant Awards may provide certification at the institutional level.
(4) Nothing herein restricts the Institute
				from requiring the Grant Recipient to demonstrate an amount of Encumbered Funds
				greater than one-half of the Grant Award available and not yet expended that
				are dedicated to the research that is the subject of the Grant Award. To the
				extent that a greater Matching Funds amount will be required, the Institute
				shall include the requirement in the Request for Applications and in the Grant
				Contract.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.12 - Limitation on Use of Funds

Current through Reg. 49, No. 28; July 12, 2024
(a) A Grant
				Recipient may use Grant Award funds only for Cancer Research and Cancer
				Prevention projects consistent with the purpose of the Act, and in accordance
				with the Grant Contract. Grant Award funds may not be used for purposes other
				than those purposes for which the grant was awarded. The Institute may require
				a Grant Recipient to repay Grant Award funds if the Grant Recipient fails to
				expend the Grant Award funds in accordance with the terms and conditions of the
				Grant Contract and the provisions of this chapter.
(b) A Grant Recipient of Grant Award funds
				for a Cancer Research or Cancer Prevention project may not spend more than five
				percent (5%) of the Grant Award funds for Indirect Costs.
(c) The Institute may not award more than
				five percent (5%) of the total Grant Award funds for each fiscal year to be
				used for facility purchase, construction, remodel, or renovation purposes
				during any year. Any Grant Award funds that are to be expended by a Grant
				Recipient for facility purchase, construction, remodel, or renovations are
				subject to the following conditions:
(1) The
				use of Grant Award funds must be specifically approved by the Chief Executive
				Officer with notification to the Oversight Committee;
(2) Grant Award funds spent on facility
				purchase, construction, remodel, or renovation projects must benefit Cancer
				Prevention and Research;
(3) If
				Grant Award funds are used to build a capital improvement, then the state
				retains a lien or other interest in the capital improvement in proportion to
				the percentage of the Grant Award funds used to pay for the capital
				improvement. If the capital improvement is sold, then the Grant Recipient
				agrees to repay to the state the Grant Award funds used to pay for the capital
				improvement, with interest, and share with the state a proportionate amount of
				any profit realized from the sale.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.13 - Audits and Investigations

Current through Reg. 49, No. 28; July 12, 2024
(a)
				Upon request and with reasonable notice, an entity receiving Grant Award funds
				directly under the Grant Contract or indirectly through a subcontract under the
				Grant Contract shall allow, or shall cause the entity that is maintaining such
				items to allow the Institute, or auditors or investigators working on behalf of
				the Institute, including the State Auditor and/or the Comptroller of Public
				Accounts for the State of Texas, to review, inspect, audit, copy or abstract
				its records pertaining to the specific Grant Contract during the term of the
				Grant Contract and for the three year period following the date the last
				disbursement of funds is made by the Institute or all reports required pursuant
				to the Grant Contract are submitted and approved, whichever date is later.
(1) A Grant Recipient shall maintain its
				records pertaining to the specific Grant Contract for a period of three years
				following the date the last disbursement of funds is made by the Institute or
				all reports required pursuant to the Grant Contract are submitted and approved,
				whichever date is later.
(2) The
				Grant Recipient may maintain its records in either electronic or paper
				format.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.14 - Termination, Extension, Close Out of Grant Contracts, and De-Obligation of Grant Award Funds

Current through Reg. 49, No. 28; July 12, 2024
(a) The termination
				date of a Grant Contract shall be the date stated in the Grant Contract,
				except:
(1) The Chief Executive Officer may
				elect to terminate the Grant Contract earlier because the Grant Recipient has
				failed to fulfill contractual obligations, including timely submission of
				required reports or certifications;
(2) The Institute terminates the Grant
				Contract because funds allocated to the Grant Award are reduced, depleted, or
				unavailable during the award period, and the Institute is unable to obtain
				additional funds for such purposes; or
(3) The Institute and the Grant Recipient
				mutually agree to terminate the Grant Contract earlier.